Andree B, Duprez D, Vorbusch B, Arnold HH, Brand T (1998) BMP-2 induces ectopic expression of cardiac lineage markers and interferes with somite formation in chicken embryos. Mech Dev 70: 119-131.
Andrews PW (1998) Teratocarcinomas and human embryology: pluripotent human EC cell lines. Review article. Apmis 106: 158-167; discussion 167-158.
Barron M, Gao M, Lough J (2000) Requirement for BMP and FGF signaling during cardiogenic induction in non-precardiac mesoderm is specific, transient, and cooperative. Dev Dyn 218: 383-393.
Bassus S, Herkert O, Kronemann N, Gorlach A, Bremerich D, Kirchmaier CM, Busse R, Schini-Kerth VB (2001) Thrombin causes vascular endothelial growth factor expression in vascular smooth muscle cells: role of reactive oxygen species. Arterioscler Thromb Vasc Biol 21: 1550-1555.
Beenken A, Mohammadi M (2009) The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov 8: 235-253.
Behfar A, Zingman LV, Hodgson DM, Rauzier JM, Kane GC, Terzic A, Puceat M (2002) Stem cell differentiation requires a paracrine pathway in the heart. Faseb J 16: 1558-1566.
Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F et al. (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763-776.
Bouche G, Gas N, Prats H, Baldin V, Tauber JP, Teissie J, Amalric F (1987) Basic fibroblast growth factor enters the nucleolus and stimulates the transcription of ribosomal genes in ABAE cells undergoing G0----G1 transition. Proc Natl Acad Sci U S A 84: 6770-6774.
Braga LM, Rosa K, Rodrigues B, Malfitano C, Camassola M, Chagastelles P, Lacchini S, Fiorino P, De Angelis K, Schaan BD, Irigoyen MC, Nardi NB (2008) Systemic delivery of adult stem cells improves cardiac function in spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 35: 113-119.
Bruneau BG (2002) Transcriptional regulation of vertebrate cardiac morphogenesis. Circ Res 90: 509-519.
Bugler B, Amalric F, Prats H (1991) Alternative initiation of translation determines cytoplasmic or nuclear localization of basic fibroblast growth factor. Mol Cell Biol 11:
573-577.
Bundesamt S (2005) Amtlich gemeldete Sterbefälle nach den häufigsten Todesursachen. Fortbeschreibung des Bevölkerungsstandes und Todesursachenstatistik.
Carrier RL, Papadaki M, Rupnick M, Schoen FJ, Bursac N, Langer R, Freed LE, Vunjak-Novakovic G (1999) Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng 64: 580-589.
Chassagne C, Wisnewsky C, Schwartz K (1993) Antithetical accumulation of myosin heavy chain but not alpha-actin mRNA isoforms during early stages of pressure-overload-induced rat cardiac hypertrophy. Circ Res 72: 857-864.
Choi M, Stottmann RW, Yang YP, Meyers EN, Klingensmith J (2007) The bone morphogenetic protein antagonist noggin regulates mammalian cardiac morphogenesis.
Circ Res 100: 220-228.
Cibelli JB, Grant KA, Chapman KB, Cunniff K, Worst T, Green, HL, Walker SJ, Gutin PH, Vilner L, Tabar V, Dominko T, Kane J, Wettstein PJ, Lanza RP, Studer L, Vrana KE, West MD (2002) Parthenogenetic stem cells in nonhuman primates. Science 295: 819.
Coughlin, S. R. (1999). "How the protease thrombin talks to cells." Proc Natl Acad Sci U S A 96: 11023-7.
Corda S, Samuel JL, Rappaport L (2000) Extracellular matrix and growth factors during heart growth. Heart Fail Rev 5: 119-130.
Cucina A, Borrelli V, Lucarelli M, Sterpetti AV, Cavallaro A, Strom R, Santoro-DÁngelo L, Scarpa S (2002) Autocrine production of basic fibroblast growth factor translated from novel synthesized mRNA mediates thrombin-induced mitogenesis in smooth muscle cells. Cell Biochem Funct 20: 39-46.
Dang CV (1991) C-myc oncoprotein function. Biochim Biophys Acta 1072: 103-113.
Dell'Era P RR, Coco L, Nicoli S, Metra M, Presta M. (2003) Fibroblast growth factor receptor-1 is essential for in vitro cardiomyocyte development. Circ Res 93: 414-420.
Detillieux KA, Sheikh F, Kardami E, Cattini PA (2003) Biological activities of fibroblast growth factor-2 in the adult myocardium. Cardiovasc Res 57: 8-19.
Dimmeler S, Zeiher AM, Schneider MD (2005) Unchain my heart: the scientific foundations of cardiac repair. J Clin Invest 115: 572-583.
Doetschman T, Shull M, Kier A, Coffin JD (1993) Embryonic stem cell model systems for vascular morphogenesis and cardiac disorders. Hypertension 22: 618-629.
Dono R, Texido G, Dussel R, Ehmke H, Zeller R (1998) Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. Embo J 17: 4213-4225.
Dreger P, Glass B, Seyfarth B, Humpe A, Claviez A, von Neuhoff N, Suttorp M, Schoch R, Schmitz N (2000) Reduced-intensity allogeneic stem cell transplantation as salvage treatment for patients with indolent lymphoma or CLL after failure of autologous SCT.
Bone Marrow Transplant 26: 1361-1362.
Dudley AT, Lyons KM, Robertson EJ (1995) A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9: 2795-2807.
Dvorak P, Dvorakova D, Hampl A (2006) Fibroblast growth factor signaling in embryonic and cancer stem cells. FEBS Lett 580: 2869-2874.
Ellis CA, Malik AB, Gilchrist A, Hamm H, Sandoval R, Voyno-Yasenetskaya T, Tiruppathi C (1999) Thrombin induces proteinase-activated receptor-1 gene expression in endothelial cells via activation of Gi-linked Ras/mitogen-activated protein kinase pathway. J Biol Chem 274: 13718-13727.
Epstein JA, Buck CA (2000) Transcriptional regulation of cardiac development:
implications for congenital heart disease and DiGeorge syndrome. Pediatr Res 48: 717-724.
Eschenhagen T, Fink C, Remmers U, Scholz H, Wattchow J, Weil J, Zimmermann W, Dohmen HH, Schafer H, Bishopric N, Wawatsuki T, Elson EL (1997) Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. Faseb J 11: 683-694.
Evans MJ, Kaufman MH (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292: 154-156.
Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor.
Endocr Rev 18: 4-25.
Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G (1987) Structural characterization and biological functions of fibroblast growth factor. Endocr Rev 8: 95-114.
Guan K, Nayernia K, Maier LS, Wagner S, Dressel R, Lee LH, Nolte J, Wolf F, Li M, Engel W, Hasenfuss G (2006) Pluripotency of spermatogonial stem cells from adult mouse testis. Nature 44: 1199-1203.
Hampton TG, Amende I, Fong J, Laubach VE, Li J, Metais C, Simons M (2000) Basic FGF reduces stunning via a NOS2-dependent pathway in coronary-perfused mouse hearts. Am J Physiol Heart Circ Physiol 279: H260-268.
Hanafusa H, Ninomiya-Tsuji J, Masuyama N, Nishita M, Fujisawa J, Shibuya H, Matsumoto K, Nishida E (1999) Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression. J Biol Chem 274:
27161-27167.
Hung DT, Wong YH, Vu TK, Coughlin SR (1992) The cloned platelet thrombin receptor couples to at least two distinct effectors to stimulate phosphoinositide hydrolysis and inhibit adenylyl cyclase. J Biol Chem 267: 20831-20834.
Kanno S, Kim PK, Sallam K, Lei J, Billiar TR, Shears LL (2004) Nitric oxide facilitates cardiomyogenesis in mouse embryonic stem cells. Proc Natl Acad Sci U S A 101:
12277-12281.
Katoh M (2006) FGF signaling network in the gastrointestinal tract (review). Int J Oncol 29: 163-168.
Kaufman MH, Robertson EJ, Handyside AH, Evans MJ (1983) Establishment of pluripotential cell lines from haploid mouse embryos. J Embryol Exp Morphol 73: 249-261.
Kawai T, Takahashi T, Esaki M, Ushikoshi H, Nagano S, Fujiwara H, Kosai K (2004) Efficient cardiomyogenic differentiation of embryonic stem cell by fibroblast growth factor 2 and bone morphogenetic protein 2. Circ J 68: 691-702.
Kehat I, Kenyagin-Karsenti D, Snir M, Segev H, Amit M et al. (2001) Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 108: 407-414.
Khezri S, Valojerdi MR, Sepehri H, Baharvand H (2007) Effect of basic fibroblast growth factor on cardiomyocyte differentiation from mouse embryonic stem cells. Saudi Med J 28: 181-186.
Klug MG, Soonpaa MH, Koh GY, Field LJ (1996) Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts. J Clin Invest 98:
216-224.
Koch WJ, Hawes BE, Allen LF, Lefkowitz RJ (1994) Direct evidence that Gi-coupled receptor stimulation of mitogen-activated protein kinase is mediated by G beta gamma activation of p21ras. Proc Natl Acad Sci U S A 91: 12706-12710.
Kopp JB (2000) BMP receptors in kidney. Kidney Int 58: 2237-2238.
Koyanagi M, Haendeler J, Badorff C, Brandes RP, Hoffmann J, Pandur P, Zeiher AM, Kuhl M, Dimmeler S (2005) Non-canonical Wnt signaling enhances differentiation of human circulating progenitor cells to cardiomyogenic cells. J Biol Chem 280: 16838-16842.
Kruithof BP vWB, Somi S, Kruithof-de Julio M, Pérez Pomares JM, Weesie F, Wessels A, Moorman AF, van den Hoff MJ (2006) BMP and FGF regulate the differentiation of multipotential pericardial mesoderm into the myocardial or epicardial lineage. Dev Biol 295: 507-522.
Laflamme MA, Murry CE (2005) Regenerating the heart. Nat Biotechnol 23: 845-856.
Lavine KJ, Yu K, White AC, Zhang X, Smith C, Partanen J, Ornitz DM (2005) Endocardial and epicardial derived FGF signals regulate myocardial proliferation and differentiation in vivo. Dev Cell 8: 85-95.
Lee KF, Simon H, Chen H, Bates B, Hung MC, Hauser C (1995) Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 378: 394-398.
Li RK YT, Weisel RD, Mickle DA, Sakai T, Choi A, Jia ZQ (2000) Construction of a bioengineered cardiac graft. J Thorac Cardiovasc Surg 119: 368-375.
Littler CM, Morris KG, Jr., Fagan KA, McMurtry IF, Messing RO (2003) Protein kinase C-epsilon-null mice have decreased hypoxic pulmonary vasoconstriction. Am J Physiol Heart Circ Physiol 284: H1321-1331.
Liu Y, Song J, Liu W, Wan Y, Chen X (2003) Growth and differentiation of rat bone marrow stromal cells: does 5-azacytidine trigger their cardiomyogenic differentiation?
Cardiovasc Res 58: 460-468.
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
Lopez AD, Murray CC (1998) The global burden of disease, 1990-2020. Nat Med 4:
1241-1243.
Lough J, Barron M, Brogley M, Sugi Y, Bolender DL (1996) Combined BMP-2 and FGF-4, but neither factor alone, induces cardiogenesis in non-precardiac embryonic mesoderm. Dev Biol 178: 198-202.
Lyons GE, Schiaffino S, Sassoon D, Barton P, Buckingham M (1990) Developmental regulation of myosin gene expression in mouse cardiac muscle. J Cell Biol 111: 2427-2436.
Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R (2001) Proteinase-activated receptors. Pharmacol Rev 53: 245-282.
Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H (1999) Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103: 697-705.
Maltsev VA, Rohwedel J, Hescheler J, Wobus AM (1993) Embryonic stem cells differentiate in vitro into cardiomyocytes representing sinusnodal, atrial and ventricular cell types. Mech Dev 44: 41-50.
Massague J (1990) The transforming growth factor-beta family. Annu Rev Cell Biol 6:
597-641.
Massague J (1998) TGF-beta signal transduction. Annu Rev Biochem 67: 753-791.
McMahon JA, Takada S, Zimmerman LB, Fan CM, Harland RM (1998) Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite. Genes Dev 12: 1438-1452.
Menasche P, Hagege AA, Desnos M (2005) Myoblast transplantation for heart failure:
where are we heading. Arch Mal Coeur Vaiss 98: 649-654.
Menasche P, Hagege A, Scorsin M, Pouzet B, Desnos M (2001) Autologous skeletal myoblast transplantation for cardiac insufficiency. First clinical case]. Arch Mal Coeur Vaiss 94: 180-182.
Mignatti P, Morimoto T, Rifkin DB (1992) Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol 151: 81-93.
Mima T, Ueno H, Fischman DA, Williams LT, Mikawa T (1995) Fibroblast growth factor receptor is required for in vivo cardiac myocyte proliferation at early embryonic stages of heart development. Proc Natl Acad Sci U S A 92(2): 467-471.
Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M (2003) The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113:
631-642.
Monzen K, Shiojima I, Hiroi Y, Kudoh S, Oka T (1999) Bone morphogenetic proteins induce cardiomyocyte differentiation through the mitogen-activated protein kinase kinase kinase TAK1 and cardiac transcription factors Csx/Nkx-2.5 and GATA-4. Mol Cell Biol 19: 7096-7105.
Moore KL (1996) Embryologie; Lehrbuch und Atlas der Entwicklungsgeschichte des Menschen. Schattauer Stuttgart.
Murry CE, Field LJ, Menasche P (2005) Cell-based cardiac repair: reflections at the 10-year point. Circulation 112: 3174-3183.
Nakamura T, Sano M, Songyang Z, Schneider MD (2003) A Wnt- and beta -catenin-dependent pathway for mammalian cardiac myogenesis. Proc Natl Acad Sci U S A 100:
5834-5839.
Niwa H, Miyazaki J, Smith AG (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24: 372-376.
Niwa H, Masui S, Chambers I, Smith AG, Miyazaki J (2002) Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells. Mol Cell Biol 22: 1526-1536.
Nohe A, Keating E, Knaus P, Petersen NO (2004) Signal transduction of bone morphogenetic protein receptors. Cell Signal 16: 291-299.
Olofsson B, Pajusola K, Kaipainen A, von Euler G, Joukov V et al. (1996) Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proc Natl Acad Sci U S A 93: 2576-2581.
Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A (2003) Bone marrow stem cells regenerate infarcted myocardium. Pediatr Transplant 7 Suppl 3: 86-88.
Ornitz DM, Itoh N (2001) Fibroblast growth factors. Genome Biol 2: 3005.
Palcy S, Goltzman D (1999) Protein kinase signalling pathways involved in the up-regulation of the rat alpha1(I) collagen gene by transforming growth factor beta1 and bone morphogenetic protein 2 in osteoblastic cells. Biochem J 343: 21-27.
Pandur P, Lasche M, Eisenberg LM, Kuhl M (2002) Wnt-11 activation of a non-canonical Wnt signalling pathway is required for cardiogenesis. Nature 418: 636-641.
Paquin J, Danalache BA, Jankowski M, McCann SM, Gutkowska J (2002) Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes. Proc Natl Acad Sci U S A 99: 9550-9555.
Polesskaya A, Seale P, Rudnicki MA (2003) Wnt signaling induces the myogenic specification of resident CD45+ adult stem cells during muscle regeneration. Cell 113:
841-852.
Pountos I, Jones E, Tzioupis C, McGonagle D, Giannoudis PV (2006) Growing bone and cartilage. The role of mesenchymal stem cells. J Bone Joint Surg Br 88: 421-426.
Rathjen PD, Lake J, Whyatt LM, Bettess MD, Rathjen J (1998) Properties and uses of embryonic stem cells: prospects for application to human biology and gene therapy.
Reprod Fertil Dev 10: 31-47.
Reddi AH (1994) Bone and cartilage differentiation. Curr Opin Genet Dev 4: 737-744.
Rogge C (2007) Entwicklung und Charakterisierung einer neuen in vitro-Herzmuskelmodells aus embryonalen Stammzellen. Med Dissertation Universität Hamburg.
Rohwedel J, Guan K, Wobus AM (1999) Induction of cellular differentiation by retinoic acid in vitro. Cells Tissues Organs 165: 190-202.
Rosen V, Thies RS (1992) The BMP proteins in bone formation and repair. Trends Genet 8: 97-102.
Rosenblatt-Velin N, Lepore MG, Cartoni C, Beermann F, Pedrazzini T (2005) FGF-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes.
J Clin Invest 115: 1724-1733.
Saga Y, Miyagawa-Tomita S, Takagi A, Kitajima S, Miyazaki J (1999) MesP1 is expressed in the heart precursor cells and required for the formation of a single heart tube. Development 126: 3437-3447.
Sakurai H, Miyoshi H, Mizukami J, Sugita T (2000) Phosphorylation-dependent activation of TAK1 mitogen-activated protein kinase kinase kinase by Tab1. Febs Lett 474: 141-145.
Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355:
1210-1221.
Schlange T, Andree B, Arnold HH, Brand T (2000) BMP2 is required for early heart development during a distinct time period. Mech Dev 91: 259-270.
Schlueter J, Manner J, Brand T (2006) BMP is an important regulator of proepicardial identity in the chick embryo. Dev Biol 295: 546-558.
Scholer HR, Dressler GR, Balling R, Rohdewohld H, Gruss P (1990) Oct-4: a germline-specific transcription factor mapping to the mouse t-complex. Embo J 9: 2185-2195.
Schultheiss TM, Burch JB, Lassar AB (1997) A role for bone morphogenetic proteins in the induction of cardiac myogenesis. Genes Dev 11: 451-462.
Shimizu H, Zhang X, Zhang J, Leontovich A, Fei K (2002) Epithelial morphogenesis in hydra requires de novo expression of extracellular matrix components and matrix metalloproteinases. Development 129: 1521-1532.
Skerjanc IS (1999) Cardiac and skeletal muscle development in P19 embryonal carcinoma cells. Trends Cardiovasc Med 9: 139-143.
Solloway MJ, Harvey RP (2003) Molecular pathways in myocardial development: a stem cell perspective. Cardiovasc Res 58: 264-277.
Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C (2003) Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361: 45-46.
Stottmann RW, Anderson RM, Klingensmith J (2001) The BMP antagonists Chordin and Noggin have essential but redundant roles in mouse mandibular outgrowth. Dev Biol 240: 457-473.
Sugi Y, Sasse J, Lough J (1993) Inhibition of precardiac mesoderm cell proliferation by antisense oligodeoxynucleotide complementary to fibroblast growth factor-2 (FGF-2).
Dev Biol 157: 28-37.
Taha MF, Valojerdi MR, Mowla SJ (2007) Effect of bone morphogenetic protein-4 (BMP-4) on cardiomyocyte differentiation from mouse embryonic stem cell. Int J Cardiol 120:
92-101.
Takahashi T, Lord B, Schulze PC, Fryer RM, Sarang SS, Gullans SR, Lee RT (2003) Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes.
Circulation 107: 1912-1916.
Takei S, Ichikawa H, Johkura K, Mogi A, No H, Yoshie S, Tomotsune D, Sasaki K (2009) Bone morphogenetic protein-4 promotes induction of cardiomyocytes from human embryonic stem cells in serum-based embryoid body development. Am J Physiol Heart Circ Physiol 296: H1793-1803.
Taylor SJ, Chae HZ, Rhee SG, Exton JH (1991) Activation of the beta 1 isozyme of phospholipase C by alpha subunits of the Gq class of G proteins. Nature 350: 516-518.
Terami H, Hidaka K, Katsumata T, Iio A, Morisaki T (2004) Wnt11 facilitates embryonic stem cell differentiation to Nkx2.5-positive cardiomyocytes. Biochem Biophys Res Commun 325: 968-975.
Urist MR, Sato K, Brownell AG, Malinin TI, Lietze A, Huo YK, Prolo DJ, Oklund S, Finerman GA, DeLange RJ (1983) Human bone morphogenetic protein (hBMP). Proc Soc Exp Biol Med 173: 194-199.
Van Wijk B, Moorman AF, van den Hoff MJ (2007) Role of bone morphogenetic proteins in cardiac differentiation. Cardiovasc Res 74: 244-255.
Ventura C, Zinellu E, Maninchedda E, Maioli M (2003) Dynorphin B is an agonist of nuclear opioid receptors coupling nuclear protein kinase C activation to the transcription of cardiogenic genes in GTR1 embryonic stem cells. Circ Res 92: 623-629.
Vlodavsky I, Miao HQ, Medalion B, Danagher P, Ron D (1996) Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer Metastasis Rev 15: 177-186.
Wan M, Cao X (2005) BMP signaling in skeletal development. Biochem Biophys Res Commun 328: 651-657.
Weissman IL (2000) Stem cells: units of development, units of regeneration, and units in evolution. Cell 100: 157-168.
Wobus AM, Hescheler J (1992) Development of an in vitro cardiomyocytes cell model for embryotoxicological and pharmacological studies. Altex 9: 29-42.
Wobus AM, Maurer R (1993) Grundung der Arbeitsgruppe "In vitro-Pharmako-Toxikologie" im Rahmen der GZG. Altex 10: 72.
Wobus AM, Kaomei G, Shan J, Wellner MC, Rohwedel J, Ji G, Fleischmann B, Katus HA, Hescheler J, Franz WM (1997) Retinoic acid accelerates embryonic stem cell-derived cardiac differentiation and enhances development of ventricular cardiomyocytes.
J Mol Cell Cardiol 29: 1525-1539.
Wright JA, Huang A (1996) Growth factors in mechanisms of malignancy: roles for TGF-beta and FGF. Histol Histopathol 11: 521-536.
Wu X, Ding S, Ding Q, Gray NS, Schultz PG (2004) Small molecules that induce cardiomyogenesis in embryonic stem cells. J Am Chem Soc 126: 1590-1591.
Xu C, Police S, Rao N, Carpenter MK (2002) Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ Res 91: 501-508.
Yang LJ, Zeller CB, Shaper NL, Kiso M, Hasegawa A, Shapiro RE, Schnaar RL (1996) Gangliosides are neuronal ligands for myelin-associated glycoprotein. Proc Natl Acad Sci U S A 93: 814-818.
Yayon A, Klagsbrun M (1990) Autocrine regulation of cell growth and transformation by basic fibroblast growth factor. Cancer Metastasis Rev 9: 191-202.
Yuasa S, Itabashi Y, Koshimizu U, Tanaka T, Sugimura K, Kinoshita M, Hattori F, Fukami S, Shimazaki T, Ogawa S, Okano H, Fukuda K (2005) Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nat Biotechnol 23: 607-611.
Zhang H, Bradley A (1996) Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 122: 2977-2986.
Zimmerman LB, De Jesus-Escobar JM, Harland RM (1996) The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86: 599-606.
Zimmermann WH, Eschenhagen T (2007) Embryonic stem cells for cardiac muscle engineering. Trends Cardiovasc Med 17: 134-140.
Zimmermann WH, Fink C, Kralisch D, Remmers U, Weil J, Eschenhagen T (2000) Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes.
Biotechnol Bioeng 68: 106-114.
Zimmermann WH, Didie M, Doker S, Melnychenko I, Naito H, Rogge C, Tiburcy M, Eschenhagen T (2006a) Heart muscle engineering: an update on cardiac muscle replacement therapy. Cardiovasc Res 71: 419 429.
Zimmermann WH, Schneiderbanger K, Schubert P, Didie M, Munzel F, Heubach JF, Kostin S, Neuhuber WL, Eschenhagen T (2002a) Tissue engineering of a differentiated cardiac muscle construct. Circ Res 90: 223-230.
Zimmermann WH, Didie M, Wasmeier GH, Nixdorff U, Hess A, Melnychenko I, Boy O, Neuhuber WL, Weyand M, Eschenhagen T (2002b) Cardiac grafting of engineered heart tissue in syngenic rats. Circulation 106: 151-157.
Zimmermann WH, Melnychenko I, Wasmeier G, Didie M, Naito H, Nixdorff U, Hess A, Budinsky L, Brune K, Michaelis B, Dhein S, Schwoerer A, Ehmke H, Eschenhagen T (2006b) Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 12: 452-458.